跳至主要内容
临床试验/CTRI/2025/03/081722
CTRI/2025/03/081722尚未招募不适用

A randomized controlled, open labelled clinical trial comparing the efficacy of carbetocin versus oxytocin in prevention of post partum hemorrhage.

DR. V. BHUVANESHWARAN1 个研究点 分布在 1 个国家目标入组 170 人开始时间: 2025年3月11日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
170
试验地点
1
主要终点
Primary outcome is to compare the efficacy of carbetocin and oxytocin in preventing intraoperative blood loss

研究概览

简要总结

To summarise this study, postpartum haemorrhage is a major concern nowadays in high-risk patients for PPH undergoing cesarean section. although oxytocin is a gold standard drug in preventing PPH  and carbetocin a novel drug came to the market with flying colours is used to prevent PPH, comparing these two drugs by administering to high risk PPH patients who are all undergoing c section.

in this study we can measure the hemodynamic variability in both intra operative as well post operative period.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • 1.Women aged 18 yrs to 50 years.
  • 2.Multiple pregnancy.
  • 3.Scheduled for Elective cesarean section under spinal anaesthesia.
  • 4.Prolonged third stage labour.
  • 5.Fetal macrosomia.
  • 6.History of post partum hemorrhage.
  • 7.Grand multiparity.
  • 8.Placenta previa.
  • 9.Placental abruption.
  • 10.Pregnancy induced hypertension.
  • 11.ASA I and II.

排除标准

  • 1.Patient refusal.
  • 2.History of thromboembolic disorder.
  • 3.Patients suffering from other chronic illness like COPD or any active LRTI.
  • 4.Preexisting neuropathy.
  • 5.Eclampsia and HELLP syndrome.
  • 6.Contraindication to Spinal anesthesia.
  • 7.Any known allergy to local anaesthetia or general anaesthesia.

结局指标

主要结局

Primary outcome is to compare the efficacy of carbetocin and oxytocin in preventing intraoperative blood loss

时间窗: 1.(T0) at carbetocin /oxytocin injection. | 2.(T1) end of operation procedure. | 3. (T3) 2 hr post operative period. | 4. (T4) 12 hr post operative period.

次要结局

  • haemodynamic variable(after administering two drugs take taken in T1 min)

研究者

发起方
DR. V. BHUVANESHWARAN
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DR V Bhuvaneshwaran

Department of anaesthesiology

研究点 (1)

Loading locations...

相似试验